Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia

Suna et al., Med. Clin. (Barc.), doi:10.1016/j.medcli.2021.04.010

May 2021

Source PDF All Studies Meta AnalysisMeta

Retrospective 323 hospitalized patients, 153 treated with vitamin C, showing no significant differences. Patients in each group were in different time periods, with the vitamin C group first. Time based confounding is possible due to improvements in SOC.

Although the 21% lower mortality is not statistically significant, it is consistent with the significant 20% lower mortality [10‑29%] from meta analysis of the 38 mortality results to date.

This is the 25th of 64 COVID-19 controlled studies for vitamin C, which collectively show efficacy with p=0.00000022. 17 studies are RCTs, which show efficacy with p=0.00000014. This study is excluded in the after exclusion results of meta analysis: substantial confounding by time likely due to declining usage over the early stages of the pandemic when overall treatment protocols improved dramatically.

Important missing comments or errors? Let us know.

risk of death, 21.3% lower, RR 0.79, p = 0.52, treatment 17 of 153 (11.1%), control 24 of 170 (14.1%), NNT 33.

risk of ICU admission, 1.9% higher, RR 1.02, p = 1.00, treatment 11 of 153 (7.2%), control 12 of 170 (7.1%).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates

Suna et al., 11 May 2021, retrospective, Turkey, peer-reviewed, 5 authors.

All Studies Meta Analysis Submit Updates or Corrections

This Paper Vitamin C All

Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia

Uzel S ¸ ener Kavurgacı Suna, Uzel Şener Melahat, Yıldız Murat, Öztürk Ergür Figen, Öztürk Ayperi

Medicina Clínica, doi:10.1016/j.medcli.2021.04.010

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre -including this research content -immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

Conflict of interest The authors declare that they have no conflict of interest.

References

Alhazzani, Møller, Arabi, Loeb, Gong, Surviving sepsis campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19), Intensive Care Med, doi:10.1007/s00134-020-06022-5

Aziz, Fatima, Assaly, Elevated interleukin-6 and severe COVID-19: a metaanalysis, J Med Virol, doi:10.1186/1743-7075-3-35

Barness, Safety considerations with high ascorbic acid dosage, Ann N Y Acad Sci, doi:10.1080/1478721020201794819

Campbell, Steinberg, Bower, Letter: ascorbic acidinduced hemolysis in G-6-PD deficiency, Ann Intern Med, doi:10.1111/j.1749-6632.1975.tb29311.xb

Cheng, Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)?, Med Drug Discov, doi:10.1016/j.medidd.2020.100028

Fijen, Weijmer, Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency, BMJ Case Rep, doi:10.7326/0003-4819-82-6-810_1

Fowler, Truwit, Hite, Morris, Dewilde, Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial, JAMA, doi:10.1016/j.chest.2016.11.036

Fujii, Luethi, Young, Frei, Eastwood et al., Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and free of vasopressor support among patients with septic shock: the vitamins randomized clinical trial, JAMA, doi:10.1093/jn/137.7.1757

Hiedra, Lo, Elbashabsheh, Gul, Wright et al., The use of IV vitamin C for patients with COVID-19: a case series, Expert Rev Anti Infect Ther, doi:10.21037/apm-20-1387

Hiedra, Lo, Elbashabsheh, Gul, Wright et al., The use of IV vitamin C for patients with COVID-19: a case series, Expert Rev Anti Infect Ther, doi:10.1001/jama.2019.22176

Jayawardena, Sooriyaarachchi, Chourdakis, Jeewandara, Ranasinghe, Enhancing immunity in viral infections, with special emphasis on COVID-19: a review, Diabetes Metab Syndr, doi:10.1007/s00134-020-06022-5

Johnston, Beezhold, Mostow, Swan, Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults, J Nutr, doi:10.1016/j.medidd.2020.100028

Johnston, Corte, Swan, Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults, Nutr Metab, doi:10.1186/s13054-018-2191-x

Li, Evidence is stronger than you think: a meta-analysis of vitamin C use in patients with sepsis, Crit Care, doi:10.1186/s13054-018-2191-x

Marik, Khangoora, Rivera, Hooper, Catravas, Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study, Chest, doi:10.7326/0003-4819-140-7-200404060-00010

Medcli-, None

Mehta, Mcauley, Brown, Sanchez, Tattersall et al., COVID-19: consider cytokine storm syndromes and immunosuppression, Lancet, doi:10.1016/S0140-6736(20)30628-0

Padayatty, Sun, Wang, Riordan, Hewitt et al., Vitamin C pharmacokinetics: implications for oral and intravenous use, Ann Intern Med, doi:10.1080/14787210.2020.1794819

Suna, Melahat, Murat, None, Medicina Clínica xxx

Wang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus infected pneumonia in Wuhan, China, JAMA, doi:10.1002/jmv.25948

Zhao, Ling, Li, Peng, Huang et al., Beneficial aspects of high dose intravenous vitamin C on patients with COVID-19 pneumonia in severe condition: a retrospective case series study, Ann Palliat Med, doi:10.1001/jama.2020.1585

Late treatment
is less effective

Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.

Submit

@CovidAnalysis

FAQ

Public domain CC0 1.0